That’s it for Advanced Practice Weekly, guys. We’ll see you soon. Take care, everybody, and be safe.
Results presented here showed patients with type 2 diabetes who used GLP-1 receptor agonists had significantly decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback